Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 168 of 168 entries
View as:

The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.

Phase: N/A Priority: Normal
NCT ID: NCT00303264 Org: User:
Start: 05/31/06 End: 08/31/07 Due: 08/31/08

Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)

Phase: N/A Priority: Normal
NCT ID: NCT00513682 Org: User:
Start: 07/31/07 End: 04/30/08 Due: 04/30/09

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression

Phase: N/A Priority: Normal
NCT ID: NCT02670551 Org: User:
Start: 03/17/16 End: 07/19/17 Due: 07/19/18

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01629966 Org: User:
Start: 06/30/12 End: 03/31/14 Due: 03/31/15

Pharmacokinetic Study of Ondansetron Administered as IR (Zofran) and MR (EUR1025)

Phase: N/A Priority: Normal
NCT ID: NCT01036854 Org: User:
Start: 02/28/09 End: 04/30/09 Due: 04/30/10

Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients

Phase: N/A Priority: Normal
NCT ID: NCT00097942 Org: User:
Start: 08/31/04 End: 09/30/05 Due: 09/30/06

An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

Phase: N/A Priority: Normal
NCT ID: NCT00765999 Org: User:
Start: 10/31/08 End: 01/31/12 Due: 01/31/13

Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure

Phase: N/A Priority: Normal
NCT ID: NCT01920074 Org: User:
Start: 06/30/13 End: 04/30/15 Due: 04/30/16

Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg

Phase: N/A Priority: Normal
NCT ID: NCT01358708 Org: User:
Start: 06/30/10 End: 09/30/11 Due: 09/30/12

Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)

Phase: N/A Priority: Normal
NCT ID: NCT00981487 Org: User:
Start: 02/28/09 End: 03/31/09 Due: 03/31/10

Acamprosate Initiated During Alcohol Detoxification

Phase: N/A Priority: Normal
NCT ID: NCT00360594 Org: User:
Start: 10/31/06 End: 11/30/07 Due: 11/30/08

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01059539 Org: User:
Start: 02/28/10 End: 02/29/12 Due: 02/28/13

Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT01386112 Org: User:
Start: 09/30/11 End: 10/31/12 Due: 10/31/13

Safety and Efficacy of Cariprazine in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01104779 Org: User:
Start: 04/27/10 End: 12/15/11 Due: 12/15/12

A Study to Determine the Effect of Nitroglycerin Ointment 0.4% (Cellegesic) on the Pain Associated With Chronic Anal Fissures

Phase: N/A Priority: Normal
NCT ID: NCT00522041 Org: User:
Start: 08/31/07 End: 07/31/08 Due: 07/31/09

Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)

Phase: N/A Priority: Normal
NCT ID: NCT01617200 Org: User:
Start: 12/31/12 End: 03/31/15 Due: 03/31/16

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

Phase: N/A Priority: Normal
NCT ID: NCT00990327 Org: User:
Start: 11/30/09 End: 04/30/12 Due: 04/30/13

An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Phase: N/A Priority: Normal
NCT ID: NCT01592786 Org: User:
Start: 06/30/12 End: 08/31/13 Due: 08/31/14